(Q46118120)

English

Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG).

scientific article published on 19 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG). (English)

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

0 references

multiple myeloma

1 reference

based on heuristic

inferred from title

Efstathios Kastritis

1

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

Athanasios Dimopoulos

16

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

author name string

K Zervas

2

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

A Symeonidis

3

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

E Terpos

4

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

S Delimbassi

5

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

N Anagnostopoulos

6

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

E Michali

7

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

A Zomas

8

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

E Katodritou

9

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

D Gika

10

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

A Pouli

11

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

D Christoulas

12

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

M Roussou

13

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

Z Kartasis

14

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

T Economopoulos

15

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

language of work or name

1 reference

based on heuristic

inferred from title

publication date

19 February 2009

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

23

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

1152-1157

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

6

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

https://scigraph.springernature.com/pub.10.1038/leu.2008.402

0 references

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

International staging system for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase 2 study of bortezomib in relapsed, refractory myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

First thalidomide clinical trial in multiple myeloma: a decade

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent major improvement in long-term survival of younger patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival in multiple myeloma and the impact of novel therapies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression profiling and multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.402

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2008.402

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19225533

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46118120&oldid=1636389604"